DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma

Abstract

Here, primary effusion lymphoma (PEL) is a rare large B-cell neoplasm particularly affecting immunodeficient hosts with an increased incidence in young or middle-aged males infected with the HIV.1 The clinical outcome of patients with PEL is unfavorable with a median survival of <6 months.1 PEL has been closely associated with human herpes virus 8 (HHV8, previously called Kaposi sarcoma herpesvirus) infection.1 In some cases a coinfection of HHV8 with the Epstein–Barr Virus (EBV) has been described.1 HHV8 encodes various genes homologous to cellular genes that have proliferative and anti-apoptotic functions.2 Although HHV8 is supposed to be a major driver of PEL, it alone is not sufficient for a full-blown lymphomagenesis.2 PEL usually shows complex karyotypes with many chromosomal aberrations.3 This chromosomal complexity might be driven by the viral infection and lead to genetic alterations cooperating with HHV8 in PEL lymphomagenesis.4

Authors:
 [1];  [2];  [3];  [4];  [1];  [5];  [1];  [6];  [6];  [1]
  1. Univ. Hospital Schleswig-Holstein, Christian-Albrechts-Univ., Kiel (Germany)
  2. Los Alamos National Lab. (LANL), Los Alamos, NM (United States)
  3. Univ. Hospital of Cologne, Cologne (Germany)
  4. Deutsches Krebsforschungszentrum Heidelberg (DKFZ), Heidelberg (Germany)
  5. Leibniz-Institute DSMZ, Braunschweig (Germany)
  6. Wellcome Trust Cancer Sanger Institute, Hinxton (United Kingdom)
Publication Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1248630
Report Number(s):
LA-UR-15-20054
Journal ID: ISSN 0887-6924; leu201522
Grant/Contract Number:  
AC52-06NA25396
Resource Type:
Accepted Manuscript
Journal Name:
Leukemia
Additional Journal Information:
Journal Volume: 29; Journal Issue: 7; Journal ID: ISSN 0887-6924
Publisher:
Nature Publishing Group (NPG)
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES

Citation Formats

Wagener, R., Alexandrov, L. B., Montesinos-Rongen, M., Schlesner, M., Haake, A., Drexler, H. G., Richter, J., Bignell, G. R., McDermott, U., and Siebert, R. Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma. United States: N. p., 2015. Web. doi:10.1038/leu.2015.22.
Wagener, R., Alexandrov, L. B., Montesinos-Rongen, M., Schlesner, M., Haake, A., Drexler, H. G., Richter, J., Bignell, G. R., McDermott, U., & Siebert, R. Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma. United States. https://doi.org/10.1038/leu.2015.22
Wagener, R., Alexandrov, L. B., Montesinos-Rongen, M., Schlesner, M., Haake, A., Drexler, H. G., Richter, J., Bignell, G. R., McDermott, U., and Siebert, R. Wed . "Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma". United States. https://doi.org/10.1038/leu.2015.22. https://www.osti.gov/servlets/purl/1248630.
@article{osti_1248630,
title = {Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma},
author = {Wagener, R. and Alexandrov, L. B. and Montesinos-Rongen, M. and Schlesner, M. and Haake, A. and Drexler, H. G. and Richter, J. and Bignell, G. R. and McDermott, U. and Siebert, R.},
abstractNote = {Here, primary effusion lymphoma (PEL) is a rare large B-cell neoplasm particularly affecting immunodeficient hosts with an increased incidence in young or middle-aged males infected with the HIV.1 The clinical outcome of patients with PEL is unfavorable with a median survival of <6 months.1 PEL has been closely associated with human herpes virus 8 (HHV8, previously called Kaposi sarcoma herpesvirus) infection.1 In some cases a coinfection of HHV8 with the Epstein–Barr Virus (EBV) has been described.1 HHV8 encodes various genes homologous to cellular genes that have proliferative and anti-apoptotic functions.2 Although HHV8 is supposed to be a major driver of PEL, it alone is not sufficient for a full-blown lymphomagenesis.2 PEL usually shows complex karyotypes with many chromosomal aberrations.3 This chromosomal complexity might be driven by the viral infection and lead to genetic alterations cooperating with HHV8 in PEL lymphomagenesis.4},
doi = {10.1038/leu.2015.22},
journal = {Leukemia},
number = 7,
volume = 29,
place = {United States},
year = {Wed Feb 04 00:00:00 EST 2015},
month = {Wed Feb 04 00:00:00 EST 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 16 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Primary effusion lymphomas exhibit complex and recurrent cytogenetic abnormalities
journal, January 2002


Primary Body Cavity-Based AIDS-Related Lymphomas
journal, February 1996

  • Ansari, M. Qasim; Dawson, D. Brian; Nador, Roland
  • American Journal of Clinical Pathology, Vol. 105, Issue 2
  • DOI: 10.1093/ajcp/105.2.221

The Role of Cytidine Deaminases on Innate Immune Responses against Human Viral Infections
journal, January 2013

  • Vieira, Valdimara C.; Soares, Marcelo A.
  • BioMed Research International, Vol. 2013
  • DOI: 10.1155/2013/683095

APOBEC3B is an enzymatic source of mutation in breast cancer
journal, February 2013

  • Burns, Michael B.; Lackey, Lela; Carpenter, Michael A.
  • Nature, Vol. 494, Issue 7437
  • DOI: 10.1038/nature11881

Signatures of mutational processes in human cancer
journal, August 2013

  • Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C.
  • Nature, Vol. 500, Issue 7463
  • DOI: 10.1038/nature12477

Reverse engineering of regulatory networks in human B cells
journal, March 2005

  • Basso, Katia; Margolin, Adam A.; Stolovitzky, Gustavo
  • Nature Genetics, Vol. 37, Issue 4
  • DOI: 10.1038/ng1532

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus
journal, June 2004

  • Hong, Young-Kwon; Foreman, Kimberly; Shin, Jay W.
  • Nature Genetics, Vol. 36, Issue 7
  • DOI: 10.1038/ng1383

Functional Genomic Relationships in HIV‐1 Disease Revealed by Gene‐Expression Profiling of Primary Human Peripheral Blood Mononuclear Cells
journal, June 2005

  • Ockenhouse, Christian F.; Bernstein, Wendy B.; Wang, Zhining
  • The Journal of Infectious Diseases, Vol. 191, Issue 12
  • DOI: 10.1086/430321

Microarray Analysis of Lymphatic Tissue Reveals Stage-Specific, Gene Expression Signatures in HIV-1 Infection
journal, July 2009

  • Li, Qingsheng; Smith, Anthony J.; Schacker, Timothy W.
  • The Journal of Immunology, Vol. 183, Issue 3
  • DOI: 10.4049/jimmunol.0803222

Signatures of mutational processes in human cancer.
text, January 2013

  • Alexandrov, Ludmil B.; Nik-Zainal Abidin, Serena; Wedge, David C.
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.31889

Works referencing / citing this record:

Clock-like mutational processes in human somatic cells
journal, November 2015

  • Alexandrov, Ludmil B.; Jones, Philip H.; Wedge, David C.
  • Nature Genetics, Vol. 47, Issue 12
  • DOI: 10.1038/ng.3441

The effects of mutational processes and selection on driver mutations across cancer types
journal, May 2018


Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference
journal, April 2019


Understanding mutagenesis through delineation of mutational signatures in human cancer
journal, May 2016


Mutational signatures associated with tobacco smoking in human cancer
journal, November 2016


Biology and management of primary effusion lymphoma
journal, November 2018


Mutational signatures associated with tobacco smoking in human cancer
posted_content, May 2016

  • Alexandrov, Ludmil B.; Ju, Young Seok; Haase, Kerstin
  • bioRxiv
  • DOI: 10.1101/051417

The effects of mutational processes and selection on driver mutations across cancer types
posted_content, June 2017

  • Temko, Daniel; Tomlinson, Ian P. M.; Severini, Simone
  • bioRxiv
  • DOI: 10.1101/149096

Author Correction: The effects of mutational processes and selection on driver mutations across cancer types
journal, April 2020


Discovering novel mutation signatures by latent Dirichlet allocation with variational Bayes inference
journal, April 2019


The ubiquitous ‘cancer mutational signature’ 5 occurs specifically in cancers with deleted FHIT alleles
journal, November 2017